Claims

Every tracked claim and what happened to it, newest first.

25,080 total · showing 25,001–25,080

• Marathon Digital — IP acquisition, development and monetization business stated · 2013-02-04
• Marathon Digital — Sampo IP LLC acquisition stated · 2013-02-04
• Riot — Four directors resigned September 26, 2012 stated · 2012-10-14
• Riot — Pursuing FDA regulatory clearance for AppyScore™ stated · 2012-10-14
• Riot — Exclusive license agreement for animal health intellectual property stated · 2012-10-14
• Riot — Common stock offering initiated in 2012 stated · 2012-10-14
• Riot — AppyScore™ blood-based diagnostic test for appendicitis stated · 2012-10-14
• Riot — Stock Incentive Plan share reserve increase stated · 2011-05-31
• Riot — Stock Incentive Plan term extension to July 8, 2021 not_yet_verifiable · 2011-05-31
• Riot — Authorization for reverse stock split at ratios 1-for-2 to 1-for-6 prior to February 4, 2011 not_yet_verifiable · 2010-10-21
• Riot — Amendment to 2002 Stock Incentive Plan increasing shares reserved stated · 2010-10-21
• Riot — GHP Horwath appointed as independent registered public accounting firm for fiscal year 2011 not_yet_verifiable · 2010-10-21
• Riot — Board restructuring: Gail Schoettler becomes non-executive Chair, Daryl Faulkner steps down as Executive Chairman stated · 2010-10-21
• Riot — Stephen T. Lundy appointed Chief Executive Officer and President stated · 2010-10-21
• Riot — Stock Incentive Plan increase by 700,000 shares stated · 2010-10-11
• Riot — Board authorization for reverse stock split up to 1-for-6 by February 4, 2011 not_yet_verifiable · 2010-10-11
• Riot — GHP Horwath, P.C. as independent auditor for fiscal year 2011 not_yet_verifiable · 2010-10-11
• Riot — Lead Director designation eliminated stated · 2010-10-11
• Riot — Vice Chairman office eliminated stated · 2010-10-11
• Riot — Daryl Faulkner stepped down from Executive Chairman role stated · 2010-10-11
• Riot — Gail Schoettler appointed non-executive Chair of the Board stated · 2010-10-11
• Riot — Independent accounting firm ratification stated · 2009-10-15
• Riot — Stock incentive plan expansion stated · 2009-10-15
• Applied Digital — Pacific Stock Transfer Company as transfer agent stated · 2008-09-25
• Applied Digital — Broadridge for proxy solicitation services stated · 2008-09-25
• Applied Digital — Wolf & Company, P.C. as independent auditor stated · 2008-09-25
• Applied Digital — Joseph J. Luca as Audit Committee financial expert stated · 2008-09-25
• Applied Digital — Kenneth Wood as Chief Executive Officer stated · 2008-09-25
• Applied Digital — Neal Fine as director stated · 2008-09-25
• Applied Digital — William B. Cotton as director stated · 2008-09-25
• Applied Digital — Wes Cummins as director stated · 2008-09-25
• Applied Digital — James A. Schwartz as director stated · 2008-09-25
• Applied Digital — Joseph J. Luca as director stated · 2008-09-25
• Applied Digital — Wolf & Company appointed as independent auditors not_yet_verifiable · 2007-09-24
• Applied Digital — Joseph J. Luca as Audit Committee financial expert stated · 2007-09-24
• Applied Digital — Captain Bill Cotton and Dr. Neal Fine joining Board not_yet_verifiable · 2007-09-24
• Applied Digital — Board members retiring not_yet_verifiable · 2007-09-24
• Applied Digital — Samuel Kovnat retiring as Chairman not_yet_verifiable · 2007-09-24
• Applied Digital — SEC investigation closure stated · 2006-09-13
• Applied Digital — R&D contract backlog for SOCRATES® technology stated · 2006-09-13
• Applied Digital — TIICM countermeasure live fire testing stated · 2006-09-13
• Applied Digital — UNICORN technology development financing stated · 2006-09-13
• Applied Digital — UNICORN radar antenna proof-of-concept success stated · 2006-09-13
• Applied Digital — Denver International Airport testing resumption stated · 2006-09-13
• Applied Digital — Department of Transportation Volpe Center contract stated · 2006-09-13
• Applied Digital — SOCRATES® detection performance stated · 2006-09-13
• TeraWulf — Toshifumi Komatsu Vice President of Technology stated · 2006-03-23
• TeraWulf — Jon Gerlach Chief Financial Officer stated · 2006-03-23
• TeraWulf — Claude P. Piguet Executive Vice President stated · 2006-03-23
• TeraWulf — William C. Ulland CEO and Chairman stated · 2006-03-23
• TeraWulf — Form S-8 registration statement filed for stock plan stated · 2006-03-23
• TeraWulf — McGladrey & Pullen selected as independent auditor not_yet_verifiable · 2006-03-23
• Riot — Holding company restructuring stated · 2005-09-25
• Riot — Company name change to AspenBio Pharma, Inc. stated · 2005-09-25
• Riot — Authorized shares increase stated · 2005-09-25
• Riot — Stock Incentive Plan share increase stated · 2005-09-25
• Riot — Roger D. Hurst employment terminated stated · 2005-09-25
• Riot — David E. Welch joined Board of Directors stated · 2005-09-25
• Riot — Douglas I. Hepler joined Board of Directors stated · 2005-09-25
• Riot — Jeffrey G. McGonegal appointed CFO stated · 2005-09-25
• Riot — Richard G. Donnelly elected Director stated · 2005-09-25
• Riot — Richard G. Donnelly appointed President and CEO stated · 2005-09-25
• Riot — Antigen business acquisition from Vitro Diagnostics stated · 2005-09-25
• TeraWulf — Independent auditor retention for 2005 not_yet_verifiable · 2005-03-24
• TeraWulf — Board director elections for 2005 not_yet_verifiable · 2005-03-24
• Riot — Markets over 30 products to diagnostic test manufacturers and research facilities stated · 2004-09-13
• Riot — StayBred requires FDA approval or ANDA filing stated · 2004-09-13
• Riot — SurBred 15 antigen-based blood test not subject to FDA regulation stated · 2004-09-13
• Riot — Roger Hurst exclusive employment agreement stated · 2004-09-13
• Riot — Pipeline products in development stated · 2004-09-13
• Riot — StayBred recombinant luteinizing hormone for cattle pregnancy maintenance stated · 2004-09-13
• Riot — SurBred 15 early detection bovine pregnancy test stated · 2004-09-13
• Riot — License arrangements with three universities stated · 2004-09-13
• Riot — Merial exclusive marketing and distribution rights for SurBred 15 stated · 2004-09-13
• Riot — CFO appointment stated · 2004-04-04
• Riot — Director appointment stated · 2004-04-04
• Riot — Acquisition of antigen business from Vitro Diagnostics stated · 2004-03-23
• Riot — Douglas I. Hepler stock options stated · 2004-03-23
• Riot — Jeffrey G. McGonegal appointed Chief Financial Officer stated · 2004-03-23
• Riot — Douglas I. Hepler appointed to Board of Directors stated · 2004-03-23